Pharma deals during September 2013 PMLiVE Similar concerns are faced by Indian authorities as KKR has announced its intention to acquire 40 pre cent of generics company Gland Pharma for around $500m. Gland, established ... The lead pipeline candidates are SGI-110, a subcutaneous ... |
